JLE

Epileptic Disorders

MENU

Epilepsia partialis continua associated with the p.Arg403Cys variant of the DNM1L gene: an unusual clinical progression with two episodes of super-refractory status epilepticus with a 13-year remission interval Volume 24, issue 1, February 2022

  • [1] Wakabayashi J., Zhang Z., Wakabayashi N., Tamura Y., Fukaya M., Kensler T.W. The dynamin-related GTPase Drp1 is required for embryonic and brain development in mice. J Cell Biol. 2009;186:805-816. 6
  • [2] Waterham H.R., Koster J., van Roermund C.W.T., Mooyer P.A.W., Wanders R.J.A., Leonard J.V. A lethal defect of mitochondrial and peroxisomal fission. N Engl J Med. 2007;356:1736-1741. 17
  • [3] Fahrner J.A., Liu R., Perry M.S., Klein J., Chan D.C. A novel dominant negative mutation in DNM1L impairs mitochondrial fission and presents as childhood epileptic encephalopathy. Am J Med Genet A. 2016;170:2002-2011. de novo8
  • [4] Ladds E., Whitney A., Dombi E., Hofer M. DNM1L mutation associated with mitochondrial epilepsy syndrome with fever sensitivity. Neurol Genet. 2018;4:e258. De novo
  • [5] Mccormack M., Mcginty R., Zhu X., Slattery L., Heinzen E.L., Consortium E. mutations in patients with chronic ultra-refractory epilepsy with onset after age five years. Eur J Med Genet. 2020;63:103625. De-novo1
  • [6] Nolan D.A., Chen B., Michon A.M., Salatka E., Arndt D. A Rasmussen encephalitis, autoimmune encephalitis, and mitochondrial disease mimicker: expanding the DNM1L-associated intractable epilepsy and encephalopathy phenotype. Epileptic Disord. 2019;21:112-116. 1
  • [7] Ryan C.S., Fine A.L., Cohen A.L., Schiltz B.M., Renaud D.L., Wirrell E.C. DNM1L variant in a teenager with progressive paroxysmal dystonia and lethal super-refractory myoclonic status epilepticus. J Child Neurol. 2018;33:651-658. De novo10
  • [8] Schmid S.J., Wagner M., Goetz C., Makowski C., Freisinger P., Berweck S. A dominant negative mutation in DNM1L causes sudden onset status epilepticus with subsequent epileptic encephalopathy. Neuropediatrics. 2019;50:197-201. de novo3
  • [9] Mancardi M.M., Nesti C., Febbo F., Cordani R., Siri L., Nobili L. Focal status and acute encephalopathy in a 13-year-old boy with DNM1L mutation: video-polygraphic pattern and clues for differential diagnosis. Brain Dev. 2021;43:644-651. de novo5
  • [10] Verrigni D., Di Nottia M., Ardissone A., Baruffini E., Nasca A., Legati A. Clinical-genetic features and peculiar muscle histopathology in infantile DNM1L-related mitochondrial epileptic encephalopathy. Hum Mutat. 2019;40:601-618. 5
  • [11] Pan Z., Wu T.H., Chen C., Peng P., He Y.W., Yi W.Z. gene variant caused encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1: three cases report and literature review. Zhonghua Er Ke Za Zhi. 2021;2:400-406. DNM1L59
  • [12] Molteni E., Perego P., Zanotta N., Reni G. Entropy analysis on EEG signal in a case study of focal myoclonus. Annu Int Conf IEEE Eng Med Biol Soc. 2008;2008:4724-4727.
  • [13] Guerrini R., Takahashi T. Myoclonus and epilepsy. Handbook of clinical neurology. 2013.
  • [14] Mameniškienė R., Wolf P. Epilepsia partialis continua: a review. Seizure. 2017;44:74-80.
  • [15] Ferlazzo E., Trenite D.K.-N., de Haan G.-J., Felix Nitschke F., Ahonen S., Gasparini S. Update on pharmacological treatment of progressive myoclonus epilepsies. Curr Pharm Des. 2017;23:5662-5666. 37